Scalper1 News
Shares of Actavis set a new high but then reversed direction in early trading Wednesday after the Irish drugmaker topped quarterly sales and profit views, helped by a big rise in sales of branded drugs. Actavis (ACT) also said that it will change its name to Allergan (AGN) after its $66 billion buyout of the Botox maker closes later this year. That deal, announced in November, is the third-biggest health care acquisition ever in the U.S., Scalper1 News
Scalper1 News